Skip to main content
2026 ACVIM Forum Main banner
Icon Legend
This session is not on your agenda.
This session is on your agenda. Click again to remove it.
Presentation Icons
ACVIM Resident Research Award Eligible
ACVIM Resident Research Award Eligible
Additional Fees May Be Required
Additional Fees May Be Required
By Invite Only
By Invite Only
Capturing for On Demand
Capturing for On Demand
Cardiology Research Abstract Award Eligible
Cardiology Research Abstract Award Eligible
ERC Approved Lecture for ACVIM Residency
ERC Approved Lecture for ACVIM Residency
Poster
Poster
Livestream
Livestream
One Health
One Health
Pre-Registration Required
Pre-Registration Required
Research Abstract
Research Abstract
Specialty Symposium
Specialty Symposium
ACVIM Resident Research Award Winner
ACVIM Resident Research Award Winner
Cardiology Research Abstract Award Winner
Cardiology Research Abstract Award Winner
ViewAttendees 2

Oncology

Panel: Omics-Driven Precision Medicine in Canine Oncology

Friday, June 12, 2026
1:30 PM - 3:45 PM PT
Location: Summit SCC, Room 320
CE: 2.25 Medical Hours

Sponsored by 
Capturing for On Demand ERC Approved Lecture for ACVIM Residency
Disclosure(s):
Lucas Rodrigues, DVM, MS, PhD: No financial relationships to disclose
Maciej Parys, DVM,PhD: CanCan Diagnostics: Shareholder, owner (Ongoing)
William Hendricks, PhD: CanCan Diagnostics: Advisor (Ongoing); Kyrexa: Advisor (Ongoing); MI:RNA Diagnostics: Fractional Chief Product Officer; fees, equity options (Ongoing); Strategic Healthcare Advisors: Advisor (Ongoing)
Guannan Wang, PhD: No financial relationships to disclose
Presentation Description / Summary: The rapid expansion of genomic and molecular profiling in veterinary oncology is reshaping how we understand, diagnose, and treat canine cancers. This panel will bring together leading experts in canine cancer omics, Lucas Rodrigues, Will Hendricks, Guannan Wang, and Maciej Parys, to discuss recent large-scale sequencing efforts, key recurrent genomic alterations, and their clinical relevance. To set the stage, panelists will review how genomics has reshaped cancer patient stratification and treatment. The discussion will then highlight the comparative oncology perspective: how insights from human cancer research initially guided our understanding in dogs, and how veterinary-specific clinical evidence is now driving prognostic and therapeutic correlations. Attendees will gain a deeper understanding of how clinico-genomic data can inform diagnosis, prognosis and therapeutic options, and advance precision medicine approaches for canine patients.

Learning Objectives:

  • Understand the impact of large-scale genomic profiling on canine cancer care: how recurrent genomic alterations inform patient stratification, prognosis, and give new opportunities for treatment.
  • Recognize the role of comparative oncology in advancing veterinary precision medicine: moving from leveraging human cancer data to establishing veterinary-specific clinical evidence that supports prognostic and therapeutic correlations in dogs.